Introduction
In utero gene transfer to muscle has significant potential to treat genetic disorders that are ongoing at birth and are currently incurable, such as the most common form of muscular dystrophy, Duchenne muscular dystrophy (DMD). Several groups have reported in utero gene delivery to muscle using first-generation adenoviral (Ad) vectors. [1] [2] [3] [4] [5] However, delivery of a full-length 14 kb dystrophin cDNA for treatment of DMD will require the larger carrying capacity of a high-capacity Ad (HCAd) vector. 6 As a step toward fetal gene transfer for DMD, it is important to explore the effect of retargeting HC-Ad vectors to fetal muscle receptors to improve the safety and efficiency of vector delivery.
The classically described pathway of Ad infection involves binding of the viral fiber protein to the coxsackievirus and adenovirus receptor (CAR), followed by internalization mediated by the interaction of viral penton base with a v b 3 and a v b 5 integrins. [7] [8] [9] [10] Recently, it was recognized that Ad fiber interacts with heparan sulfate glycosaminoglycans (HSG), playing a role in cell transduction by Ad serotypes 2 and 5. 11, 12 An emerging area of viral vector development is the modification of Ad tropism by incorporating small peptide ligands into the capsid proteins. 13 We and others have explored different strategies for muscle-specific targeting in adult mouse muscle. [14] [15] [16] [17] [18] However, vector retargeting to enhance fetal gene transfer of muscle or other tissues has not been reported previously for any viral or nonviral vectors. Incorporation of an Arg-GlyAsp (RGD) peptide motif, which binds to vitronectin integrins, in the fiber knob of Ad vectors increases transduction efficiency of cells in culture. [19] [20] [21] [22] [23] [24] We hypothesized that addition of an RGD peptide motif to the HC-Ad vector would enhance transduction of 16 days postconception (E-16) mouse fetal muscle because muscle expresses high levels of a v integrin at this developmental stage. [25] [26] [27] To test this hypothesis, we compared transduction efficiencies of an RGD-modified HC-Ad (RGD-HC-Ad) vector and an unmodified HC-Ad vector in E-16 fetal muscle in vivo and in muscle cells isolated from E-16 fetal muscle in vitro. In this report, 'retargeting' of the HC-Ad vector by an RGD capsid modification refers to the addition of the capability of vector binding to a v integrins, with preservation of the native ability of vector binding to cellular CAR. This study provides the first report of in utero muscle gene delivery by HC-Ad vectors and the first attempt at vector retargeting in fetal tissue in vivo.
Results

E-16 muscle was transduced better by HC-Ad vector than by RGD-HC-Ad vector
To determine whether the inclusion of an RGD peptide in the HI loop of the HC-Ad vector fiber protein would enhance transduction of fetal muscle cells, we performed in utero intramuscular injections with 1.8 Â 10 7 blue forming units (BFU) of RGD-HC-Ad and HC-Ad vectors in fetuses of E-16 gestation pregnant C57BL/6 mice. Both vectors carried the identical lacZ gene expression cassette driven by the cytomegalovirus (CMV) promoter. At 2 days after vector administration, hind limb muscle and organs from the injected pups and the mother's liver were collected for transgene biodistribution studies.
Muscle from pups injected with HC-Ad vector demonstrated four-fold higher b-galactosidase (b-gal) activity than muscle injected with RGD-HC-Ad vector ( Figure 1a ). Histological studies confirmed the higher level of b-gal activity observed by quantitative studies in HC-Ad vector-transduced muscle as compared to RGD-HC-Ad vector-transduced muscle (Figure 1b) . We also detected transgene expression in other organs including heart, liver, lung and motheŕs liver (Figure 1a ).
Fetal muscle expressed Ad receptors
To investigate the lower transduction achieved by RGD-HC-Ad vector, we determined the expression levels of CAR and integrins a v in fetal C57BL/6 murine muscle, using integrin a 7 expression as an identification marker for muscle (Figure 2) . 28 In E-16 muscle tissue, which is known to be the stage of secondary myotube formation, we observed two histological patterns (Figure 2 ). Less mature primary myotubes 29 were positive for b 5 integrin and CAR, but negative for b 3 integrin. In contrast, more mature clusters of myotubes, 29 which likely represent secondary myotube development, expressed b 3 integrin, as well as b 5 integrin and CAR. Our observations in E-16 C57BL/6 muscle are consistent with previous reports of the changes in integrin repertoire during murine embryonic development in other mouse strains. [25] [26] [27] 30 Our data on CAR expression in E-16 fetal muscle and data generated by ourselves and others on a v integrin expression in E-16 fetal muscle suggested that the lower transduction of E-16 muscle by RGD-HC-Ad vector was not due to the lack of the principal receptors that are known to mediate Ad vector binding and internalization.
For comparison with muscle tissue, we also show the pattern of CAR and a v integrin expression in C57BL/6 E-16 fetal liver and lung. Liver showed strong staining for CAR and b 5 integrin, which was homogeneously distributed suggesting that both receptors colocalize on the same cells. b 3 integrin expression was only found on megakaryocytes. CAR and b 5 integrin were expressed in the pulmonary parenchyma, especially by airway epithelial cells. b 3 integrin expression in the lung was localized to smooth muscle cells.
Isolated primary E-16 myogenic cells expressed Ad receptors
We studied primary myogenic cells isolated from E-16 skeletal muscle to address parameters of muscle cell transduction separated from the more complicated variables found in vivo. CHO-CAR cells are CHOpc cells that are stably transduced with the CAR cDNA and, therefore, express high levels of CAR. 7, 32 In CHOpc cells, RGD-HC-Ad vector achieved a transduction level twice that of HC-Ad vector suggesting superior utilization of the RGD-a v integrin entry pathway by RGD-HC-Ad vector when CAR is not present (Figure 5a ). This result is consistent with previous studies that demonstrated improved transduction of cells that express low levels of CAR by RGD-modified Ad vectors. [19] [20] [21] [22] [23] [24] However, in CHO-CAR cells, whose sole difference from CHOpc cells is the expression of CAR, we observed that unmodified HC-Ad vector achieved six-fold higher transduction than RGD-HC-Ad vector suggesting that CAR binding provided a more efficient entry pathway than a v integrin binding (Figure 5a ). In utero targeting with high-capacity adenoviral vectors R Bilbao et al HC-Ad vector carrying a lacZ transgene led to high levels of b-gal expression in the injected leg. These data suggest that muscle gene transfer using HC-Ad in utero will be effective when applied to a therapeutic model such as the mdx dystrophin-deficient mouse model of DMD. It is interesting to compare the fetal muscle transduction by Ad vectors achieved in our studies with that reported previously by others. However, differences in fetal age at the time of gene delivery, mouse strain, vector titration procedures and vector transgene make comparisons between different studies difficult. Furthermore, our study is the first to describe the use of HC-Ad vectors for fetal gene transfer; all previous in utero Ad vector gene transfer studies were carried out with first-generation vectors. Two previous studies followed serum levels of a secreted protein expressed from an Ad vector delivered intramuscularly in utero. Jerebtsova et al 1 presented data on human growth hormone levels in B6/129 F1 mice at different time points following intramuscular delivery of AdCMVhGH at E-15. Levels of human growth hormone dropped from the highest value recorded 2 weeks after birth, but were still detectable at 7 months. Schneider et al 3 studied human factor IX levels after AdCMVhfIX delivery to the hind limb of E-15/E-16 C57BL/6J mice. The highest levels of factor IX were observed at 1 week of age with subsequent decline. The authors of these articles raise the consideration that the expanding blood volume that accompanies murine development could significantly dilute secreted proteins. Two further studies report on in utero intramuscular delivery of a lacZ gene using an Ad vector. Yang et al 5 performed intramuscular delivery of AdCMVlacZ to E-14/E-15 Balb/c fetuses and Mitchell et al 2 performed intramuscular delivery of AdCBlacZ in E-15 B6/129 F1 mice. In both studies, expression levels were assessed histologically, not quantitatively.
We performed a vector biodistribution study of fetal mice that received an intramuscular injection of HC-Ad In utero targeting with high-capacity adenoviral vectors R Bilbao et al or RGD-HC-Ad vector and demonstrated low levels of b-gal expression in liver, heart and lung, likely due to transduction of these tissues by vector that gained access to the systemic circulation. In previous studies with firstgeneration Ad vectors, spread to other organs after intramuscular delivery was more prominent in fetal mice 3,5 than in postnatal mice. 33 Using a quantitative biochemical assay for b-gal, we also detected reporter gene expression in the mother's liver after fetal intramuscular injection of HC-Ad in utero. A similar phenomenon, detected by histochemical analysis of b-gal on tissue sections, was observed by Mitchell et al 2 with intraplacental gene delivery, but not with intramuscular delivery. The infection of the mother's liver presents a potential risk of in utero gene transfer that will require further study.
The second goal of this study was to explore in utero intramuscular delivery of a genetically modified, integrin-targeted HC-Ad vector that presents an RGD motif in the HI loop of the Ad fiber. 19 The use of specific peptide ligands to retarget Ad vectors reflects remarkable progress in gene transfer research. 13 To date, however, vector retargeting has not been tested in fetal tissues. E-16 fetal muscle is an ideal setting for targeting studies due to the immaturity of the basal lamina, 34 which is a barrier for Ad vector delivery in adult mice. 16 In this study, we found that those pups that received RGD-HC-Ad vector expressed less b-gal in muscle than pups that received unmodified HC-Ad vector. Muscle development during this E-16 fetal stage is characterized by the formation of secondary myotubes on the scaffold of primary myotubes. 29 Previous reports demonstrate high a v integrin expression in fetal mouse muscle from E-13 to birth 27 with a subsequent decline after delivery. 35 We confirmed that E-16 fetal C57BL/6 mouse muscle expressed b 3 and b 5 integrins, as was previously reported for two other mouse strains, the F1 progeny of C57B and DBA inbred mice 26 and FVB/N inbred mice. 27 Therefore, absence of a v integrins to bind to the RGD motif was excluded as a possible explanation for lower transduction efficiency by RGD-HC-Ad vector. In this study, we provide the first demonstration that fetal skeletal muscle expresses CAR. The high expression levels of both CAR and a v integrins in fetal muscle likely explains the high transduction by unmodified HC-Ad vector.
To further evaluate the mechanism of HC-Ad vector transduction of muscle in utero, we isolated primary myogenic cells from E-16 fetal muscle. Like fetal muscle in vivo, primary E-16 myogenic cells expressed high levels of both CAR and a v integrins. HC-Ad vector showed increased transduction efficiency of these cells when compared to RGD-HC-Ad vector, similar to our in vivo data. Superior transduction efficiency of primary myogenic cells by unmodified HC-Ad vector was observed by quantifying levels of vector DNA, lacZ mRNA and b-gal protein expression and was, therefore, most likely due to higher levels of vector binding and internalization.
Most previous studies of RGD-modified Ad vectors report on the transduction of cell lines in vitro that express low levels of CAR. [19] [20] [21] [22] [23] Recently, Biermann et al In utero targeting with high-capacity adenoviral vectors R Bilbao et al for the infection of cells with high levels of CAR expression was provided by fiber knob competition studies. In addition, blocking with heparin or with both heparin and fiber knob demonstrated complex effects on cell transduction depending on targeting and the level of cellular CAR expression. However, the greater reduction of HC-Ad vector transduction by heparin in CHOpc cells compared to CHO-CAR cells suggests that the ability of Ad fiber to bind HSG becomes more important when the Ad fiber-CAR interaction is not available. Taken together, these results support the conclusion that the insertion of an RGD peptide motif in the HI loop of the fiber knob on HC-Ad vectors results in a lower use of the fiber-CAR interaction for Ad binding to fetal muscle that is not compensated by the additional RGDa v integrin interaction. Our studies suggest that to apply vector retargeting strategies to in utero muscle gene transfer, features of ligand-receptor binding affinity and disruption of transduction by classical pathways will need to be considered in addition to features of receptor abundance and muscle specificity.
Materials and methods
Adenoviral vectors
The construction of the HC-Ad vectors used in these studies has been described in detail previously. 19 In addition, the numbers of RGD-HC-Ad and HC-Ad vector genome copies were quantified from CsClpurified vector DNA isolated with the QIAamp DNA kit (Qiagen, Valencia, CA, USA). The sequence of primers and probe for the lacZ gene were published previously. 4 A plasmid containing the lacZ gene, pCMVb (Clontech, Palo Alto, CA, USA), was used for a lacZ DNA standard. The number of molecules of plasmid was measured by using the fluorescent dye PicoGreen (Molecular Probes, Eugene, OR, USA), which selectively binds double-stranded DNA. We calculated that one pCMVb copy weighed 5.79 Â 10 À18 g. All real-time PCR assays were performed in MicroAmp optical 96-well reaction plates (PE Applied Biosystem) with 50 ml PCR volumes each containing 10 ml of DNA (approximately 10 ng of DNA), 200 nM of each primer, 200 nM probe and 25 ml TaqMan 2 Â Universal Master Mix (PE Applied Biosystem, Foster City, CA, USA) including 8% glycerol, 1 Â TaqMan buffer A, 5 mM MgCl 2 , 400 mM dUTP, 200 mM dATP, dCTP, dGTP (each), AmpliTaq Gold (0.025 U/ml) and AmpErase UNG (0.01 U/ml). Amplification conditions were 2 min at 501C and 10 min at 951C for the first cycle, followed by 40 cycles of 951C for 15 s and 601C for 1 min. Agarose gel electrophoresis (1.5%) was used to verify the amplification of a single product. All samples and standards were run in duplicate. The BFU/vector genome of the HC-Ad vectors used was 1:65 for RGD-HC-Ad vector and 1:37 for HC-Ad vector.
Adenoviral vector delivery to E-16 fetuses
Pregnant C57BL/6 mice carrying E-16 gestations (Hilltop Laboratories, Scottsdale, PA, USA) were anesthestized with an intraperitoneal injection of 100 mg/kg of ketamine (100 mg/ml, Fort Dodge Laboratories Inc., Fort Dodge, IA, USA) and 20 mg/kg of xylazine (100 mg/ml, Fort Dodge). The abdomen of each pregnant mouse was shaved and cleaned with betadine, a 15 mm vertical incision was made through the abdominal wall and peritoneum, and the uterus was exposed. All fetal injections were made under a dissection microscope using sterile technique. Each vector (RGD-HC-Ad and HC-Ad) was diluted up to a final volume of 5 ml of buffer/fetus containing 0.05% fast green dye (Sigma, St Louis, MO, USA) in Ringer buffer. Transuterine intramuscular injections were carried out using a 33 G needle (Hamilton, Reno, NV, USA) attached by tubing to a 100 ml Hamilton syringe filled with mineral oil placed on a syringe pump. The abdomen of the pregnant mouse was closed with running 7-0 silk suture (Ethicon; Jonhson & Johnson, San Angelo, TX, USA) and the skin was closed with wound clips. To provide topical analgesia, Lidocaine cream was applied to the incision site after surgery. The animals recovered in a warm cage for up to 24 h in the surgery room. The mortality rates were 26% for fetuses injected with RGD HC-Ad vector and 24% for fetuses injected with HC-Ad vector.
Detection of b-galactosidase in fetuses by ONPG assay and X-gal staining
In order to detect b-gal expression 48 h after gene transfer, the pups were collected following euthanasia of the pregnant mouse. Selected pup organs including lung, heart and liver and muscle from the injected limb and the mother's liver were collected. Protein extracts were prepared from individual organs by adding 75 ml of TEES (25 mM Tris-HCl, pH 8.0, 2.5 mM EDTA pH 8.0, 2.5 mM EGTA pH 7.4, 5% SDS) to each sample. b-Gal activity and total protein concentration were quantified by ONPG assay 14 and the BCA Protein Assay (Pierce, Rockford, IL, USA) respectively. For the ONPG assay, serial dilutions of extract from each sample were incubated at 371C for 30 min in a 96-well plate with a buffer containing the enzyme substrate. The optical density of the reaction was read at wavelength 420 nm. b-Gal expression was expressed as units of b-gal activity per mg of protein.
For X-gal staining, 36 fetuses were fixed in 4% paraformaldehyde in PBS for 1 h, washed in PBS, incubated in 5% sucrose in PBS at 41C until specimens descended to the bottom of the tube (approximately 2-4 h), and transferred to 20% sucrose in PBS at 41C overnight. The following day, the fixed and cryoprotected fetuses were placed in preheated 7.5% (w/v) gelatin (Sigma) in 15% sucrose in PBS and left at 371C until they were submerged. After this, the blocks were incubated at 41C for 30 min until they solidified. The 6 , 1 mg/ml X-gal and 1 mM MgCl 2 ) overnight at 371C and counterstained with Harris' hematoxylin.
Primary myogenic cells and cell lines
A previously published method of myoblast isolation 37 was modified to isolate primary fetal myogenic cells from pups taken from E-16 C57BL/6 mice. Muscle tissue from the hind limbs of at least 20 fetuses was isolated for each cell preparation. After mechanical and collagenase/ dispase digestion, the cells were passed through a nylon filter and preplated for 2 h. The supernatant was then carefully transferred to a collagen-coated dish for 2 days. After the second day, the supernatant was transferred to a new collagen-coated dish. By the end of the fourth day, an enriched population of myogenic cells attached to the plate. Greater than 95% of cells were myogenic as determined by marker expression (see below). These cells were cultured using 20% fetal bovine serum (FBS), 1% chick embryo extract and 10 ng/ml basic fibroblast growth factor in F10 media.
C2C12 cell line myoblasts and 293 embryonic kidney cells were cultured in Dulbecco modified essential medium (DMEM) with 10% FBS. 3T3NIH mouse fibroblasts cells were cultured with minimal essential medium (MEM) with 10% FBS. Chinese hamster ovary (CHO) cells stably transfected with a control plasmid pcDNA3.1 (CHOpc) or CAR plasmid (CHO-CAR) were cultured in MEM with G418 antibiotic (400 mg/ml) and 10% FBS. 7 All tissue culture reagents were purchased from Invitrogen (Carlsbad, CA, USA).
Staining for desmin, CAR and a v , b 3 , b 5 and a 7 integrins Pups removed from the uteruses of E-16 C57BL/6 mice were snap frozen and stored at -801C. Cryostat sections were fixed in acetone for 7 min and nonspecific binding was blocked with 10% donkey serum (Jackson, West Grove, PA, USA) in PBS. Serial sections were incubated with each of the following antibodies: an affinity-purified rabbit antibody against CAR 38 at a dilution of 1:100, a rat antibody against a 7 integrin (a gift of Dr Randall Kramer from the University of California, San Francisco, CA, USA) at a dilution of 1:200, a hamster antibody against b 3 integrin (Pharmigen, San Jose, CA, USA) at a dilution of 1:15 and a rabbit antibody against b 5 integrin (Chemicon, Temecula, CA, USA) at a dilution of 1:200 in PBS. Antibody detection was performed with the DAB þ Chromogen Kit (Dako, Carpinteria, CA, USA) according to the manufacturer's instructions. Slides were counterstained using Harris' hematoxylin.
Primary myogenic cells were fixed with 2% paraformaldehyde containing 0.1% Triton X-100 (Sigma) for 2 min and nonspecific binding was blocked with 10% donkey serum. Cells were incubated with each of the following antibodies: a rabbit a v integrin antibody (Chemicon) at a dilution of 1:200, a b 5 integrin antibody at a dilution of 1:800 and a goat antibody against desmin at a dilution of 1:200 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in BSA solution (0.5% w/v BSA, 0.15% glycine w/v, in PBS). Positive and negative control cells for desmin were C2C12 myoblasts and 3T3NIH fibroblasts, respectively. Positive and negative controls for a v and b 5 integrin were C2C12 and 293 cells, respectively.
Fluorescence-activated cell sorting (FACS) analysis was performed on primary myogenic cells by staining either for CAR (1:1000) 38 or a 7 integrin (1:100). Stained cells were analyzed using a FACS calibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). Positive and negative controls for CAR were CHO-CAR and CHOpc cells, respectively, and for a 7 integrin were C2C12 and 3T3NIH cells, respectively.
Vector DNA and transgene RNA analysis Primary myogenic cells were infected with RGD-HC-Ad or HC-Ad vector at an MOI of 10. After 24 h, cells were collected and a protein lysate was prepared and analyzed for b-gal expression by ONPG assay as described above. Total RNA and DNA were isolated from the pellet of the primary myogenic cell lysate using TRIzol reagent (Life Technologies, Gaithersburg, MD, USA). Each DNA sample was amplified for lacZ and endogenous mouse apolipoprotein B (Apo-B) (a singlecopy gene used as an internal control) copies. Conditions for real-time PCR are described above. The sequences for the primers and probe for Apo-B were described previously. 39 Standard curves for the lacZ gene were generated using 10-fold serial dilutions of the pCMVb diluted in 10 ng of C2C12 cell line genomic DNA. A standard curve for the murine Apo-B assay was generated using a 10-fold dilution series (10 5 -1 genome copies) of C2C12 cell line genomic DNA determined by PicoGreen. The genome copies were calculated using the approximation that a murine diploid cell contains 6 pg of DNA. For RNA analysis, real-time reverse transcriptase PCR (real-time RT-PCR) was carried out using the SuperScript Preamplification System for First Strand cDNA Synthesis (Life Technologies) according to the manufacturer's instructions, followed by real-time PCR amplification of lacZ transcripts as described above. Quantification of the transcripts was performed by comparing the relative amount of lacZ mRNA against the GAPDH housekeeping gene mRNA. The sequences for GAPDH primers and probe are described in the instructions of the TaqMan 2X Universal Master Mix.
Competition assays with fiber knob protein and heparin
Fiber knob protein was generated as previously described. 19 For competition with fiber knob protein, CHOpc and CHO-CAR cells were incubated with 10 mg/ ml of fiber knob at 41C for 30 min prior to a 60 min infection by 10 MOI of HC-Ad or RGD-HC-Ad vector at 371C and 5% CO 2 . For competition with heparin (Sigma), each vector was incubated with 3 mg/ml of heparin for 20 min at room temperature prior to infecting CHOpc and CHO-CAR cells at an MOI of 10 for 60 min at 371C and 5% CO 2 . Combined block by fiber knob and heparin was carried out by incubating the cells with the fiber knob and each vector with heparin as described above prior to infection of cells. After each 60 min infection, medium containing virus was removed and fresh medium was added to the cells. LacZ transgene expression was quantified 24 h later by ONPG assay.
In utero targeting with high-capacity adenoviral vectors R Bilbao et al
Statistical analysis
Nonparametric Kruskal-Wallis and Dunn's multiple comparison tests were conducted for statistical studies. All P-values were two-tailed and were considered very statistically different (**) when the associated probability was less than 0.01.
